TP53 and ovarian cancer: The naturally occurring flavonoid dihydromyricetin, derived from the plant Vitis heyneana traditionally used in Chinese herbal medicine, induced activation of p53 and apoptosis in ovarian cancer cells resistant to paclitaxel and doxorubicin (62).